Detalhe da pesquisa
1.
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Blood
; 140(5): 451-463, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605184
2.
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output.
Mol Ther Methods Clin Dev
; 32(1): 101171, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298420
3.
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
J Clin Invest
; 132(16)2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852863
4.
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy.
Cancers (Basel)
; 13(17)2021 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503088
5.
A SNIPpet of safety: a Goldilocks approach in CAR-T therapy.
Cell Res
; 32(7): 603-604, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739237